Quick search:
| Result | Content | Outlet | Published | Research |
|---|---|---|---|---|
| Result | Content | Outlet | Published | Research |
| 1 | Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study | The BMJ | 10 days ago |
|
| 2 | Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages | Signal Transduction and Targeted Therapy | Nature.com | 24 days ago |
|
| 3 | Which COVID Variants Are Currently Spreading in the US? Here's What's Being Tracked Right Now | NBC Chicago | 1 month ago |
|
| 4 | Epidemiological analysis of the first 1000 cases of SARS‐CoV‐2 lineage BA.1 (B.1.1.529, Omicron) compared with co‐circulating Delta in Wales, UK | Wiley | 1 month ago |
|
| 5 | COVID: BA.5 symptoms, infection, what to know about omicron subvariant | USA TODAY | 23 days ago |
|
| 6 | Researchers explore SARS-CoV-2 entry route and downstream cellular and viral processes | News-Medical.Net | 2 days ago |
|
| 7 | Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection | News-Medical.Net | 18 days ago |
|
| 8 | Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection | Nature.com | 2 days ago |
|
| 9 | Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern | World Health Organization | 9 months ago |
|
| 10 | Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure | Science | 2 months ago |
|
| 11 | High‐resolution analysis of individual spike peptide‐specific CD4+ T‐cell responses in vaccine recipients and COVID‐19 patients | Wiley | 3 days ago |
|
| 12 | Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study | The Lancet | 3 days ago |
|
| 13 | How effective is previous infection in preventing reinfection with Omicron BA.4/BA.5? | News-Medical.Net | 25 days ago |
|
| 14 | Omicron Variant: What You Need to Know | CDC | 8 months ago |
|
| 15 | An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science | 8 days ago |
|
| 16 | COVID-19 vaccination increases antibodies in breast milk significantly | News-Medical.Net | 3 days ago |
|
| 17 | The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England | Science | 3 months ago |
|
| 18 | Protein-based vaccine as the booster dose for adults: evidence and beyond | The Lancet | 1 day ago |
|
| 19 | Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates | Wiley | 6 months ago |
|
| 20 | Why is the omicron variant called B.1.1.529? | Quartz | 9 months ago |
|
| 21 | Heavily mutated Omicron variant puts scientists on alert | Nature.com | 9 months ago |
|
| 22 | Omicron (B.1.1.529 variant of SARS‐CoV‐2); an emerging threat: Current global scenario | Wiley | 8 months ago |
|
| 23 | SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 | MMWR | CDC | 5 months ago |
|
| 24 | Effectiveness of third vaccine dose for coronavirus disease 2019 during the Omicron variant pandemic: a prospective observational study in Japan | Scientific Reports | Nature.com | 2 days ago |
|
| 25 | Update on Omicron | World Health Organization | 9 months ago |
|
| 26 | Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study | The Lancet | 2 months ago |
|
| 27 | OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear | Wiley | 8 months ago |
|
| 28 | Enhancing response to Omicron SARS-CoV-2 variant | World Health Organization | 7 months ago |
|
| 29 | As the omicron variant spreads across the world, here's what we know so far | CNBC | 9 months ago |
|
| 30 | Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529 | Science | 5 months ago |
|
| 31 | Threat Assessment Brief: Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA | European Centre for Disease ... | 9 months ago |
|
| 32 | Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022 | MMWR | CDC | 6 months ago |
|
| 33 | The SARS‐CoV‐2 Omicron (B.1.1.529) variant and the re‐emergence of COVID‐19 in Europe: An alarm for Bangladesh | Wiley | 5 months ago |
|
| 34 | FIRST CONFIRMED CASE OF OMICRON (B.1.1.529) COVID-19 VARIANT IDENTIFIED IN VIRGINIA | Newsroom | 8 months ago |
|
| 35 | Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention — New York City, November 18–December 20, 2021 | MMWR | CDC | 6 months ago |
|
| 36 | Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study | The Lancet | 5 months ago |
|
| 37 | Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California | Nature.com | 2 months ago |
|
| 38 | Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert! | Wiley | 9 months ago |
|
| 39 | University-Associated SARS-CoV-2 Omicron BA.2 Infections, Maricopa County, Arizona, USA, 2022 | Medscape | 3 days ago |
|
| 40 | Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective | Wiley | 5 months ago |
|
| 41 | Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant | NEJM | nejm.org | 4 months ago |
|
| 42 | Omicron: What do we know about the new COVID 'variant of concern' | Euronews | 9 months ago |
|
| 43 | New COVID Variant B.1.1.529, Which May Evade Immunity, Found in These Countries | Newsweek | 9 months ago |
|
| 44 | Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron | Nature.com | 7 months ago |
|
| 45 | Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance — One Hospital, California, July 15–September 23, 2021, | CDC | 6 months ago |
|
| 46 | The new Omicron variant is a pandemic gut check | CNN | 9 months ago |
|
| 47 | Neutralizing potency of COVID‐19 vaccines against the SARS‐CoV‐2 Omicron (B.1.1.529) variant | Wiley | 7 months ago |
|
| 48 | What We Know About Nu B.1.1.529 COVID Variant Ahead of WHO Assessment | Newsweek | 9 months ago |
|
| 49 | New data published in The New England Journal of Medicine show Evusheld retains neutralising activity against Omicron subvariants, including BA.5 | AstraZeneca | 22 days ago |
|
| 50 | Worrying Nu B.1.1.529 COVID Variant May Have Emerged in Person With Weak Immune System | Newsweek | 9 months ago |
|
| 51 | WHO advice for international traffic in relation to the SARS-CoV-2 Omicron variant (B.1.1.529) | World Health Organization | 9 months ago |
|
| 52 | The SARS‐CoV‐2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far | Wiley | 7 months ago |
|
| 53 | SARS-CoV-2 Variant Classifications and Definitions | CDC | 8 months ago |
|
| 54 | Moderna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant – PharmaLive | PharmaLive | 9 months ago |
|
| 55 | Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective | Wiley | 8 months ago |
|
| 56 | Statement on Omicron sublineage BA.2 | World Health Organization | 6 months ago |
|
| 57 | New B.1.1.529 COVID Variant Called 'Most Significant to Date' by Top U.K. Health Official | Newsweek | 9 months ago |
|
| 58 | Enter Omicron: New COVID-19 Variant Spreads Alarm | Infection Control Today | 9 months ago |
|
| 59 | A Guide to Help You Keep Up With the Omicron Subvariants | Kaiser Health News | 3 months ago |
|
| 60 | CDC confirms first U.S. case of omicron Covid variant has been detected in California | CNBC | 8 months ago |
|
| 61 | Threat Assessment Brief: Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA | first update | 8 months ago |
|
| 62 | How Worried Should We Be About the Omicron COVID Variant? What We Know so Far | NBC New York | 8 months ago |
|
| 63 | SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance — Los Angeles County, California, November 7, 2021–January 8, 2022 | MMWR | CDC | 6 months ago |
|
| 64 | Today ECDC released an updated Threat Assessment Brief on the SARS-CoV-2 variant B.1.1.529, known as Omicron. | European Centre for Disease ... | 8 months ago |
|
| 65 | Nu B.1.1.529 Variant: WHO Greek Alphabet COVID Naming System Explained | Newsweek | 9 months ago |
|
| 66 | BA.4 and BA.5, two new Omicron variants sweeping South Africa, detected in U.S. | Fortune | 3 months ago |
|
| 67 | Omicron variant of SARS-CoV-2 exhibits striking antibody evasion | News-Medical.Net | 8 months ago |
|
| 68 | #VisualAbstract: Fewer hospital admissions and death were seen with SARS-CoV-2 Delta (B.1.617.2) compared to Omicron (B.1.1.529) variant infections | 2 Minute Medicine | 4 months ago |
|
| 69 | What Is the Omicron Variant? Symptoms, COVID-19, Vaccine | MedicineNet | 8 months ago |
|
| 70 | Health officials say new omicron variant of COVID-19 appears less serious than first one | BethesdaMagazine.com | 6 months ago |
|
| 71 | Why call it BA.2.12.1? A guide to the tangled Omicron family | Nature.com | 3 months ago |
|
| 72 | Enhancing response to Omicron SARS-CoV-2 variant | World | 7 months ago |
|
| 73 | Omicron subvariants guide: An epidemiologist answers 5 essential questions | Inverse | 3 months ago |
|
| 74 | Development of a One-Step Qualitative RT-PCR Assay to Detect the SARS-CoV-2 Omicron (B.1.1.529) Variant in Respiratory Specimens | Journal of Clinical Microbiology | American Society for Microbiology | 5 months ago |
|
| 75 | Study shows that Omicron infections were associated with a substantially reduced risk of progression to severe clinical outcomes relative to Delta infections | News-Medical.Net | 2 months ago |
|
| 76 | Here's what Omicron can tell us about how COVID-19 variants are discovered | World Economic Forum | 9 months ago |
|
| 77 | Georgia State Study Finds COVID-19 Omicron Variant Leads to Less Severe Disease in Mice | Georgia State University News | 2 months ago |
|
| 78 | New Omicron Subvariants: What We Know About BA.4 and BA.5 | NBC Chicago | 2 months ago |
|
| 79 | Tracking SARS-CoV-2 variants | Tracking SARS-CoV-2 variants | 1 year ago |
|
| 80 | Less severe clinical consequences of infection with SARS-CoV-2 Omicron variant | News-Medical.Net | 7 months ago |
|
| 81 | Enhancing Readiness for Omicron (B.1.1.529): Technical Brief and Priority Actions for Member States | World Health Organization HQ, 23 December 2021 (updated from the last version published on 17 December 2021) | 8 months ago |
|
| 82 | Omicron Variant Detected in Ohio | Ohio Department of Health | Ohio Department of Health | 8 months ago |
|
| 83 | SARS-Cov-2 Omicron variant raises significant concerns about high transmissibility in China | News-Medical.Net | 1 month ago |
|
| 84 | New Covid variant: Everything we know | The Independent | 9 months ago |
|
| 85 | Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants | NEJM | nejm.org | 4 months ago |
|
| 86 | SARS-CoV-2 Omicron Variant Transmission Within Households | Medscape | 6 months ago |
|
| 87 | The Hunt for COVID Variants: How the New Omicron Variant Was Found and What We Know So Far | SciTechDaily | 9 months ago |
|
| 88 | Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection | NEJM | nejm.org | 22 days ago |
|
| 89 | Oral Statement on B.1.1.529 variant | GOV.UK | 9 months ago |
|
| 90 | New Omicron Subvariant: Symptoms, How Fast It's Spreading, and More | NBC Chicago | 3 months ago |
|
| 91 | SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons | NEJM | nejm.org | 6 months ago |
|
| 92 | Tracking COVID-19 variant Omicron | BNO News | 9 months ago |
|
| 93 | The origin of omicron is a mystery. Here's why we need to crack the case : Goats and Soda | NPR | 8 months ago |
|
| 94 | COVID-19: 'Really awful' new coronavirus variant B.1.1.529 identified in Botswana | Sky News | 9 months ago |
|
| 95 | Omicron: what do we know about the new Covid variant? | The Guardian | 8 months ago |
|
| 96 | Newfound flavor of omicron variant may be harder to track | Livescience.com | 8 months ago |
|
| 97 | What is the new COVID-19 variant BA.2, and will it cause another wave of infections in the US? | The Conversation | 5 months ago |
|
| 98 | BioNTech testing Pfizer COVID-19 vaccine against B.1.1.529 variant | Business Insider | 9 months ago |
|
| 99 | Will Omicron BA.2 become the next dominant variant? | News-Medical.Net | 6 months ago |
|
| 100 | What is ‘stealth Omicron’? The rise of the subvariant is alarming some scientists who say it needs its own Greek letter | Fortune | 7 months ago |
|